Skip to main content
Advertising

Originally published April 4, 2012 at 5:50 PM | Page modified April 4, 2012 at 6:13 PM

  • Share:
           
  • Comments (0)
  • Print

Oncothyreon raises $50M

Seattle biotechnology company Oncothyreon said it raised gross proceeds of $54.1 million through a stock offering that sold about 13. 5 million shares. Net...

By Seattle Times business staff

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

Seattle biotechnology company Oncothyreon said it raised gross proceeds of $54.1 million through a stock offering that sold about 13.5 million shares.

Net proceeds will be about $50.3 million after deducting underwriters's discounts and other costs, said the company, which will use the funds for continue developing two drug candidates.

News where, when and how you want it

Email Icon

Career Center Blog

Career Center Blog

5 tips for fighting job burnout


Advertising